Leptin (part 2)

M.W. Schwartz, D.G. Baskin, T.R. Bukowski, J.L. Kuijper, D. Foster, G. Lasser, D.E. Prunkard, D. Porte Jr., S.C. Woods, R.J. Seeley, D.S. Weigle, "Specificity of Leptin Action on Elevated Blood Glucose Levels and Hypothalamic Neuropeptide Y Gene Expression in ob/ob Mice," Diabetes, 45: 531-5, 1996. (Cited more than 150 times since publication) Comments by Michael W. Schwartz, professor of medicine, University of Washington and Puget Sound Health Care System. Few discoveries like that of the o

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

M.W. Schwartz, D.G. Baskin, T.R. Bukowski, J.L. Kuijper, D. Foster, G. Lasser, D.E. Prunkard, D. Porte Jr., S.C. Woods, R.J. Seeley, D.S. Weigle, "Specificity of Leptin Action on Elevated Blood Glucose Levels and Hypothalamic Neuropeptide Y Gene Expression in ob/ob Mice," Diabetes, 45: 531-5, 1996. (Cited more than 150 times since publication)

Comments by Michael W. Schwartz, professor of medicine, University of Washington and Puget Sound Health Care System.

Few discoveries like that of the obese ( ob ) gene in 1994 have had such a sweeping effect on science. Traditionally regarded as an affliction due to the weak will of its sufferers, obesity is now considered a disease much like diabetes by many researchers and physicians. By 1995, scientists were discovering the enormous therapeutic potential of leptin, a protein encoded by the ob gene. Five research teams independently reported that doses of the protein normalized food intake, body weight, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies